Re: Bisphosphonates

From: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C. (johnprov@sympatico.ca)
Sat Apr 29 09:02:21 2006


At Sat, 29 Apr 2006, Jim Lie wrote: >
>Yesterday I saw a woman who has T5 & T8 crush fractures just from suddenly
>forward flexing. When we were discussing the options - including
>biphosphonates - she was aghast that I mentioned it - because she heard on
>TV about how horrible this drug is --> causing osteonecrosis. I did a google
>search and found nice lawyer sites (in USofA) asking for people to come
>forward to sue the doctors and the drug company.
>
>James Lie MBBS
>Albany
>Western Australia
>
>> >When you are treating woment with a bisphosphonate do you
>> >
>> >How long do you think she should remain on the bisphosphonates?
>> >
>>
>> Forever,--
>> Take care, John
>>

This is par for the course in any affluent society: never mind that most people who get Avascular osreonecrosis also had cancer, diabetes and peripherial vascular disease and where most likely put on on biphospantes because they where high risk for osteoporosis and osteonecrosis. Unfortantely estrogen is also associated with avascular osteonecrosis so your options for preventing osteoporosis keep getting smaller.

--
                                 Take care, John




use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Wed Jul 2 04:43:32 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.